Apeiron Investment Group Ltd. - 30 Sep 2025 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Role
10%+ Owner
Signature
Apeiron Investment Group Ltd. By: /s/ Mario Frendo, Director
Issuer symbol
ATAI
Transactions as of
30 Sep 2025
Net transactions value
$0
Form type
4
Filing time
02 Oct 2025, 16:18:56 UTC
Previous filing
18 Aug 2025
SEC
View on sec.gov

Reporting Owners (2)

Name Relationship Address Signature Signature date CIK
Apeiron Investment Group Ltd. 10%+ Owner 66 & 67 BEATRICE, AMERY STREET, SILEMA, MALTA Apeiron Investment Group Ltd. By: /s/ Mario Frendo, Director 02 Oct 2025 0001845711
Angermayer Christian Director, 10%+ Owner 66 & 67 AMERY STREET, SILEMA, MALTA /s/ Christian Angermayer 02 Oct 2025 0001845872

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATAI Common Shares Conversion of derivative security +2,367,200 +4.6% 53,412,414 30 Sep 2025 By Apeiron Investment Group Ltd. F1
holding ATAI Common Shares 1,799,302 30 Sep 2025 By Apeiron Presight Capital Fund II, L.P.

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATAI Convertible Notes Conversion of derivative security -147,950 -100% 0 30 Sep 2025 Common Shares 2,367,200 By Apeiron Investment Group Ltd. F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The conversion price for the Convertible Notes is EUR 17.00 per note.
F2 The Convertible Notes were acquired in exchange for convertible notes issued by ATAI Life Sciences AG with substantially similar terms and economics.